发明名称 Acellular Pro-Tolerogenic Compositions and Process for Making Same
摘要 This invention relates to pro-tolerogenic preparations capable of increasing the level of regulatory T cells (Treg) and/or decreasing the level of pro-inflammatory T cells (Th17) to induce anergy or immune tolerance. The pro-tolerogenic preparation is enriched in at least one species of miRNAs and is obtained by contacting two allogeneic leukocyte populations wherein at least one of the two populations is modified with a low-immunogenic biocompatible polymer. Acellular pro-tolerogenic compositions, process for making such composition as well as therapeutic uses of such compositions are also provided.
申请公布号 US2015174168(A1) 申请公布日期 2015.06.25
申请号 US201314414404 申请日期 2013.07.12
申请人 CANADIAN BLOOD SERVICES 发明人 Scott Mark D.;Wang Duncheng;Toyofuku Wendy M.
分类号 A61K35/17;C12N5/0783;A61K39/00 主分类号 A61K35/17
代理机构 代理人
主权项 1. A process for making an acellular pro-tolerogenic preparation, said process comprising: (i) associating a low-immunogenic biocompatible polymer to a cytoplasmic membrane of a first leukocyte to obtain a first modified leukocyte; (ii) contacting the first modified leukocyte with a second leukocyte under conditions to allow a pro-tolerogenic allo-recognition to provide a conditioned preparation, wherein the first leukocyte is allogeneic to the second leukocyte; (iii) removing the first modified leukocyte and the second leukocyte from the conditioned preparation under conditions to inhibit RNA degradation so as to obtain a composition enriched in acellular pro-tolerogenic components; and (iv) formulating the composition of step (iii), under conditions to inhibit RNA degradation, in the acellular pro-tolerogenic preparation for administration to a subject.
地址 Ottawa CA